AMINA Becomes the First Crypto Banking Group to Receive a MiCA License Through Its Austrian Subsidiary
3.11.2025 13:04:00 CET | Business Wire | Press Release
AMINA Bank AG (“AMINA Bank”) today announced that its newly established subsidiary, AMINA (Austria) AG (“AMINA EU”), has received a Crypto-Asset Service Provider (CASP) license from Austria’s Financial Market Authority (FMA) under the Markets in Crypto-Assets (MiCAR) framework.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103510417/en/
AMINA Expands into the EU
The FMA’s approval paves the way for AMINA EU’s launch, with regulated crypto trading, custody, and portfolio management services, as well as crypto staking, to be introduced at launch. These offerings will be available to professional investors, including family offices, corporates, financial institutions, and more.
AMINA EU, an FMA-licensed crypto-asset service provider, will offer a purpose-built platform giving clients secure, institutional-grade access to the crypto ecosystem. As a wholly owned subsidiary of AMINA Bank and a member of the global AMINA Group, it draws on proven and trusted banking-grade governance, regulatory expertise, deep industry knowledge and a strong record across multiple market cycles.
“All AMINA Group companies put clients first. AMINA EU’s receipt of a MiCA CASP license further demonstrates AMINA Group’s commitment to the highest regulatory standards and to meeting the growing global demand for trusted crypto services,” said Franz Bergmueller, CEO of AMINA Bank. “Together with our licenses in Switzerland, Hong Kong, and Abu Dhabi, this milestone enables us to offer clients global and market leading service through operations built for scale, security, and long-term success.”
Austria was chosen as AMINA EU’s European entry point because of its regulatory excellence, and strong commitment to investor protection. Already notified in thirteen additional European countries, AMINA EU is also well positioned to expand into more than thirty markets across Europe.
Eckehard Stolz, Managing Director of AMINA EU, said: “Professional investors in Europe are seeking secure, regulated access to crypto, and we’re meeting that demand with the launch of AMINA’s European operations in Austria. By combining Swiss banking DNA and deep expertise with Austrian regulatory strength, we are building the trusted infrastructure to bridge traditional finance and crypto.”
AMINA Group’s presence in Europe has been strengthened through the establishment of AMINA EU and the receipt of its CASP license, enabling the Group to better serve the European market. This license authorises AMINA EU to provide a wide range of regulated crypto-asset services: (i) custody of crypto assets, (ii) exchange of crypto assets for fiat currencies or other crypto assets, (iii) transfer services, and (iv) portfolio management of crypto assets. With this milestone, AMINA looks forward to continuing to drive and shape the growth of trusted, regulated crypto services in Austria, across Europe, and beyond.
To receive notifications on AMINA EU’s latest updates, please visit https://eu.aminagroup.com/coming-soon/
About AMINA Bank & AMINA Group — Crypto. Banking. Simplified.
Founded in April 2018 and established in Zug (Switzerland), AMINA Bank AG is a pioneer in the crypto banking industry. In August 2019, AMINA Bank AG received the Swiss Banking and Securities Dealer License from the Swiss Financial Market Supervisory Authority (“FINMA”). In February 2022, AMINA Bank AG, Abu Dhabi Global Markets (“ADGM”) Branch received Financial Services Permission from the Financial Services Regulatory Authority (“FSRA”) of ADGM to Advise on Investments or Credit, Arrange Deals in Investment, Arrange Credit and Arrange Custody for Professional Clients as defined in the Conduct of Business (“COBS”) Rulebook. In November 2023, AMINA (Hong Kong) Limited received its Type 1 (Dealing in Securities), Type 4 (Advising on Securities) and Type 9 (Asset Management) licenses from the Securities and Futures Commission (“SFC”). In October 2025, the firm’s Type 1 license was further approved for uplift to include digital asset dealing services for Professional Investors under Hong Kong’s digital asset regulatory framework. In October 2025, AMINA (Austria) AG received its CASP license from Austria’s Financial Market Authority (“FMA”) under the Markets in Crypto-Assets (MiCAR) framework.
CVVC Global Report and CB Insights named AMINA Bank AG as one of the Top 50 Companies within the blockchain ecosystem. In 2023, AMINA Bank AG won the European WealthBriefing Award in the Digital Assets Solution, Fund Manager category. AMINA Bank AG was most recently recognised as Institutional Digital Asset Innovation of the Year at the Hedgeweek® Global Digital Assets Awards 2025.
To learn more about AMINA Bank AG, visit www.aminagroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251103510417/en/
Contacts
aminabank@wachsman.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom